The era of generic chatbots is over — Verily Health is setting the beginning of a new standard in AI-enabled care with Violet, our AI health companion. Our clinical approach highlights the critical difference between a "medical chatbot" and a clinical-grade AI system. Our multi-agent architecture for symptom urgency assessment is designed for safety and precision. Here is what defines our clinical-grade AI system: ▶️ Predictable, structured outputs: Every assessment follows a strict schema, including a clear tailored education and agentic reasoning. ▶️ Ensemble reasoning: We run parallel assessments with diverse reasoning styles to reach a conservative, safety-biased consensus. ▶️ Safety by design: Multi-stage emergency detection immediately overrides the workflow for high-acuity scenarios.
Announced today at the AWS Life Sciences Symposium! Verily Workbench, our scalable trusted research environment (TRE) for biomedical data analysis and AI/ML development, is now generally available for organizations using Amazon Web Services (AWS). Workbench enables researchers to co-analyze data where it lives, accelerating discovery through integrated AI tools with built-in healthcare compliance. Key benefits of Workbench on AWS: • Secure and compliant TRE built for biomedical data • Scalable analysis with enterprise integration • Zero cloud cost markup • NVIDIA AI stack • Multicloud integration • Free standard tier accounts and data ecosystem "Verily Workbench on AWS provides the enterprise-grade TRE that will empower even more researchers to accelerate data analytics and the entire AI/ML model lifecycle, while enabling governance and collaboration," said Scott Burke, CTO at Verily Health.
💧 A Watershed Moment in Public Health Verily Health is a leader in the laboratory science behind wastewater-based epidemiology. In collaboration with scientific organizations, government agencies, and commercial organizations, our scientists conduct research to develop and validate assays needed to consistently and accurately measure the concentration of pathogens in wastewater in near real time — providing information about levels of disease spread within communities. Watch the full episode of A Watershed Moment to learn how this innovation works.
Our Chief Clinical Officer, Vindell Washington, will be keynoting the CU Anschutz Innovation Forum on April 21. This year’s focus, Pathways to Impact, addresses a core challenge that Verily Health is dedicated to solving: how to translate research and innovation into meaningful, scalable outcomes for patients. Hear our perspectives on how we are approaching these challenges, including the crucial role of data and AI in advancing more equitable and effective care, through our partnership with UCHealth, University of Colorado Anschutz, and RefinedScience. 📍 CU Anschutz Medical Campus 🗓️ April 21, 2026
The average study activation time is 9.4 months. That’s nearly triple the NCI’s 90-day target. The gap isn’t from a lack of study site effort. It’s due to complexity. In our latest Verily Viewpoint Study Start Up blog, we break down the hidden costs of delayed trial start up at AMCs and IDNs, and outline how these enterprise research sites can bring efficiency-driving structure, visibility, and predictability to activation.
We’re pleased to announce that Victor Chen, former Sr. Managing Director, Kaiser Permanente Northern California, has joined us as a strategic advisor. Victor is a seasoned clinical research leader whose deep industry expertise will be instrumental in supporting our provider and research site clients. His expertise will be a major catalyst as we work to accelerate high-impact research and bring cutting-edge treatments to patients sooner. If you’re attending WCG MAGI in a couple of weeks, hear Victor share his insights on the future of clinical operations. We’re proud to have him representing our mission on the big stage.
At the Northeast Business Group on Health event last week, Carolyn Bradner Jasik, MD, our Associate Chief Clinical Officer, discussed how employers can help their team members tackle the growing challenge of cardiometabolic disease with precision health approaches. Key insights: ➡️ Who you partner with on AI in healthcare matters: Privacy, infrastructure, and trust aren’t optional. The future of care will be AI-enabled, but only if it’s built responsibly. ➡️ Focus on value: AI should lower the cost of care and deliver savings from efficiency, not just promises of outcomes. ➡️ Look beyond point solutions: Verily Health is building the infrastructure for connected, interoperable care. Medication is only part of the solution; support and adherence are what drive outcomes. We believe AI can meet patients where they are to help with behavior change.
As Women’s History Month comes to a close, we highlight how women are disproportionately affected by health disparities — from delayed diagnoses to gaps in maternal care, chronic disease management, and mental health support. Precision health tools can offer concrete ways to help close those gaps by: • Identifying care gaps and expanding access for women in rural areas • Surfacing sex‑specific risk patterns and personalizing care by evaluating a more complete picture of a person’s health (clinical records, wearables, lifestyle, and social drivers) With better data and intentional design, we can develop better standards, recalibrated models, and care pathways that deliver more accurate, equitable outcomes for women.
The Public Health Response and Emergency Detection through Integrated Wastewater Community Testing (PREDICT) Act aims to strengthen and expand the nation’s wastewater monitoring network. This network serves as a crucial early warning system, helping public health officials quickly identify and respond to disease outbreaks. Our Chief Medical and Scientific Officer, Dr. Andrew Trister, notes the PREDICT Act, a bipartisan-supported legislation, is key to bolstering the tools every community needs to identify infectious disease threats and prevent illness. Learn more about the bill and its impact on early detection.
Our CEO Stephen Gillett joined NYSE Live! He shared how our recent funding is accelerating Verily Health’s next chapter as an independent company, with a focus on scaling our precision health AI strategy. Watch to learn how the investment will be deployed to achieve our mission of bringing the promise of precision health to everyone, every day.
